Busey Bank increased its position in shares of The Cigna Group (NYSE:CI – Free Report) by 5.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 55,688 shares of the health services provider’s stock after purchasing an additional 2,980 shares during the quarter. Busey Bank’s holdings in The Cigna Group were worth $15,378,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC grew its holdings in shares of The Cigna Group by 49,287.7% during the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock worth $138,590,000 after buying an additional 399,230 shares in the last quarter. Swedbank AB raised its holdings in The Cigna Group by 55.1% in the 4th quarter. Swedbank AB now owns 884,406 shares of the health services provider’s stock valued at $244,220,000 after acquiring an additional 314,123 shares during the last quarter. FMR LLC lifted its stake in The Cigna Group by 2.0% in the 3rd quarter. FMR LLC now owns 14,230,397 shares of the health services provider’s stock worth $4,929,978,000 after purchasing an additional 279,880 shares in the last quarter. Raymond James & Associates grew its position in shares of The Cigna Group by 42.8% in the third quarter. Raymond James & Associates now owns 860,050 shares of the health services provider’s stock valued at $297,956,000 after purchasing an additional 257,711 shares in the last quarter. Finally, Assenagon Asset Management S.A. boosted its stake in The Cigna Group by 68.4% during the fourth quarter. Assenagon Asset Management S.A. now owns 497,875 shares of the health services provider’s stock worth $137,483,000 after buying an additional 202,161 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.
The Cigna Group Price Performance
The Cigna Group stock opened at $303.49 on Thursday. The stock has a market cap of $84.42 billion, a P/E ratio of 28.63, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54. The company has a fifty day simple moving average of $296.45 and a 200-day simple moving average of $325.14. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83.
Wall Street Analyst Weigh In
A number of equities analysts have commented on the stock. Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a research report on Wednesday, October 23rd. Barclays upped their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Piper Sandler reaffirmed an “overweight” rating and set a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Finally, Stephens reaffirmed an “overweight” rating and issued a $410.00 price objective on shares of The Cigna Group in a research note on Friday, November 1st. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $395.93.
View Our Latest Stock Report on CI
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More
- Five stocks we like better than The Cigna Group
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Kimberly-Clark: A Regal Opportunity in This Dividend King
- Conference Calls and Individual Investors
- 5 Stocks With Above-Market Yields Just Raised Payments Further
- Are Penny Stocks a Good Fit for Your Portfolio?
- Arista Networks’ Stock Plunge: Buying Opportunity for Investors?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.